The pandemic prompted universities and public research organisations to re-think their IP management strategies. Various open licenses have been developed granting free temporary access to IP rights to tackle the coronavirus crisis. Do IPRs represent a barrier to access innovation in times of health emergencies?
Large healthcare datasets, Artificial Intelligence and Machine Learning can change the clinical innovation landscape. However, data access and valorisation cannot discount patients' rights; dealing with clinical data often represents a challenge for the collaboration between universities and research hospitals.
Technology Transfer: commercialising discoveries at Research Centres through linked innovation. Best practices on how to commercialise research discoveries.
The ResearchInno database: in partnership with Crunchbase, it aggregates 780,000+ companies, 29,000+ investors, 3,100+ programs and 9,900+ institutes in EU and the US
Explore this guide on how you develop a trademark protection strategy and safeguard your brand.
Join our newsletter and get the latest news